# GHK-Cu: Copper, Matrix, and Delivery > GHK-Cu Research Overview — Research Peptide Fundamentals — Core Peptides Lab — Research Peptide Fundamentals research peptides: a cited GHK-Cu overview covering copper binding, skin-matrix research, topical delivery, hair findings, and evidence limits. **REFERENCE FILE 03 / COPPER SIGNAL** A naturally occurring copper-binding tripeptide with a topical research record that depends strongly on formulation and study context. ## The short version GHK-Cu is a three-amino-acid peptide—glycine, histidine, and lysine—bound to a copper ion. The peptide occurs naturally in the body, and its copper complex is studied as a signaling and copper-delivery molecule. Most public familiarity comes from topical skincare, where it appears as Copper Tripeptide-1. Laboratory research links GHK-Cu to collagen and other parts of the skin's supporting matrix, antioxidant pathways, and wound-repair signals. Small human topical studies and reviews report changes in collagen-related measures and skin appearance, but the evidence is much narrower than broad “anti-aging” claims suggest [13][16]. A hair study reported improved counts with a combination product that contained GHK along with another active ingredient, so the result cannot isolate GHK-Cu by itself [15]. Delivery is a central issue. The native peptide crosses intact outer skin poorly, which has driven work on altered peptides, microneedles, and carrier systems [13]. Topical cosmetic use has the relevant human history. Injectable or other systemic use is unapproved and lacks validated human pharmacokinetic evidence. ## What it is GHK stands for glycyl-L-histidyl-L-lysine. GHK-Cu is the one-to-one complex formed when that tripeptide chelates, or holds, a copper(II) ion. The copper is coordinated through atoms in the glycine and histidine portions while the lysine side chain remains available. The GHK sequence occurs within proteins including type I collagen and SPARC, also called osteonectin. Free GHK and copper-bound GHK-Cu should be named separately. Copper coordination supports several reported matrix-remodeling and antioxidant actions, and a formulation that loses its bound copper may behave differently. The topical cosmetic ingredient has a distinct evidence and safety context from unapproved systemic preparations. The compound's small size does not guarantee easy delivery. A human-skin laboratory study measured penetration and retention of copper delivered as GHK-Cu over forty-eight hours, establishing a dermal depot under its experimental conditions [17]. A later review nevertheless identifies poor passage of native GHK through the stratum corneum—the skin's outer barrier—as a continuing formulation problem [13]. ## How it works GHK-Cu acts as both a copper carrier and a signaling molecule. In cell systems it stimulates dermal fibroblasts, the cells that produce structural material in skin, to make collagen, elastin, glycosaminoglycans, and decorin. It also shifts the balance between matrix metalloproteinases, which break down matrix, and their TIMP inhibitors, which restrain that breakdown. Copper contributes to enzymes involved in collagen and elastin cross-linking and antioxidant defense [16]. Gene-expression analysis has associated GHK with changes across repair, DNA maintenance, antioxidant, and protein-quality-control programs. One review reported that approximately 31.2% of examined human genes changed by at least 50%, with 59% of affected genes increasing and 41% decreasing [14]. That is a broad transcriptomic observation, not proof that the same changes translate into clinical rejuvenation. The main targets described across the corpus include fibroblasts, keratinocytes, hair-follicle dermal papilla cells, and vascular endothelial cells. The diversity of those models explains the range of research claims, while also making careful model labels essential. ## What the research shows *Topical skin evidence.* A recent review reports increased procollagen synthesis in 70% of GHK-Cu-treated subjects, compared with 50% for vitamin C and 40% for retinoic acid in the summarized studies. The same review emphasizes poor native permeability and evaluates palmitoylation and microneedle pretreatment as delivery strategies [13]. An earlier review similarly describes collagen, dermatan sulfate, chondroitin sulfate, and decorin synthesis, along with small controlled studies of skin appearance [16]. *Hair study.* In a six-month study of forty-five men with androgenetic alopecia, a combination of 5-aminolevulinic acid and GHK increased hair counts more than placebo, with no adverse events reported in any group [15]. Because the product contained two active components and did not isolate pure GHK-Cu, it is supporting evidence for a GHK-containing formulation rather than a clean test of this compound alone. *Gene programs.* Connectivity Map analysis summarized in 2018 associated GHK with changes in roughly 31.2% of genes at a 50%-change threshold, including strong representation in ubiquitin-proteasome, DNA-repair, and antioxidant sets [14]. *Skin transport.* Ex vivo human-skin research quantified copper permeation and dermal retention over forty-eight hours [17]. This supports topical formulation research but does not provide systemic human pharmacokinetics. ## Reported effects, cautions & safety The reports summarized here are **anecdotal, not clinical evidence**. Topical skincare communities very commonly mention firmer-feeling skin and softer fine lines. Hydration, a plumper appearance, smoother texture, and scalp or hair changes are also frequent themes. Reported unwanted effects include redness, itching, dryness, breakouts, and irritation when layered with strong actives. Rare reports describe uneven pigment or skin that appears worse. Accounts of injectable research use are unverified and fall outside the topical cosmetic evidence. The most defensible safety distinction is route. Topical Copper Tripeptide-1 has a cosmetic-use history, while systemic administration is unapproved and lacks validated human disposition or long-term safety data. The small human evidence base is mainly topical, and sweeping claims about whole-body repair or longevity rely heavily on cell, animal, and database work [13][16]. Copper chemistry also matters. If the complex breaks down, free copper may behave differently from intact GHK-Cu. Pigment changes and copper accumulation from prolonged systemic exposure remain theoretical or preclinical concerns in the corpus, not established common human harms. Formulation stability and skin-barrier penetration are therefore part of the evidence, not minor packaging details. ## Where it fits in Research Peptide Fundamentals GHK-Cu represents the **topical and formulation-dependent** file in the set. Its evidence is closer to human use than KPV's mouse-colitis program, but the strongest clinical signals remain small, topical, and sometimes tied to combination products. The broadest molecular claims require more direct human validation. Placed beside [BPC-157](/bpc-157), GHK-Cu shows that “repair” can refer to very different experiments: internal animal injury models on one page and topical skin-matrix measurements on another. Beside [CJC-1295](/cjc-1295), it shows why a measured molecular signal does not itself establish a health outcome. The [comparison](/compare) keeps these scopes distinct. ![Abstract GHK-Cu research illustration in aubergine and violet](/images/ghk-cu.webp) --- Core Peptides Lab is an independent reading desk for four distinct peptide research records, with study context in view and no clinical counsel offered.